Live from the NIH registry
Studies recruiting near Staten Island right now
Top 25 of 4,262 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Laura and Isaac Perlmutter Cancer Center at NYU Langone — New York, New York (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Harlem Prevention Center — New York, New York (11.8 mi)
· Sponsor: Westat
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Cancer, Period Problem
Phase 2
Interventional 60 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (11.8 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
NYC Research Inc — Long Island City, New York (15.3 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 944 participants sought
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). — New York, New York (11.8 mi)
· Sponsor: Pfizer
Mobile CBT for Middle Aged and Older Adults
Anxiety Disorders and Symptoms, Depressive Symptoms
N/A
Interventional 60 participants sought
Weill Cornell Medicine — New York, New York (11.8 mi)
· Sponsor: Weill Medical College of Cornell University
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
Cigarette Smoking
N/A
Interventional 60 participants sought
NYU Langone Health — New York, New York (11.8 mi)
· Sponsor: NYU Langone Health
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Montefiore Einstein Medical Center — The Bronx, New York (23.6 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
Colorectal Cancer
N/A
Interventional 880 participants sought
Columbia University Irving Medical Center — New York, New York (11.8 mi)
· Sponsor: Columbia University
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Stroke, Cerebrovascular Accident
N/A
Interventional 150 participants sought
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute — Edison, New Jersey (14.5 mi)
· Sponsor: Hackensack Meridian Health
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400001 — Hackensack, New Jersey (21.6 mi)
· Sponsor: Sanofi
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (11.8 mi)
· Sponsor: Erasca, Inc.
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey (17.2 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Modern Migraine, MD — New York, New York (11.8 mi)
· Sponsor: AbbVie
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
Icahn School of Medicine at Mount Sinai — New York, New York (11.8 mi)
· Sponsor: GentiBio, Inc
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — New York, New York (11.8 mi)
· Sponsor: AstraZeneca
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Newark Beth Israel Medical Center — Newark, New Jersey (10.6 mi)
· Sponsor: SWOG Cancer Research Network
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
Meniscus Tear
N/A
Interventional 80 participants sought
NYU Langone Health — New York, New York (11.8 mi)
· Sponsor: NYU Langone Health
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
Smoking Cessation
N/A
Interventional 50 participants sought
Institute for Nicotine & Tobacco Studies — New Brunswick, New Jersey (17.2 mi)
· Sponsor: Rutgers, The State University of New Jersey
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Hematologic Malignancies
Phase 2
Interventional 40 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (11.8 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Columbia University Cystic Fibrosis Program — New York, New York (11.8 mi)
· Sponsor: Jaeb Center for Health Research
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health — New York, New York (11.8 mi)
· Sponsor: Relay Therapeutics, Inc.
BioHealx® Anal Fistula Device Post Market Surveillance Study
Fistula-in-ano
N/A
Observational 50 participants sought
Northwell Health — Staten Island, New York (1.5 mi)
· Sponsor: Signum Surgical USA Inc.
Evaluating SleepWhale Drops for Rest & Resilience
Sleep
N/A
Interventional 100 participants sought
Efforia — New York, New York (11.8 mi)
· Sponsor: Efforia, Inc
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
Laura and Isaac Perlmutter Cancer Center ( Site 0034) — New York, New York (11.8 mi)
· Sponsor: Merck Sharp & Dohme LLC